Abstract:Introduction: Dendritic cells (DCs) have long been thought to function as passenger leukocytes that instigate the host anti-allograft response. However, there is cumulative evidence that DCs are not only stimulators of T cells but also play crucial roles in central and peripheral tolerance. Recently, the processing and presentation of antigens by different types of DCs have been appreciated as the initial events involved in determining immune responses. When exposed to inflammatory conditions, tolerogenic DCs, which have an immature phenotype, inhibit T cell responses and favor regulatory T cell induction/expansion. Methods: Human immune systerm has been reconstructed in NOD/SCID mouse by transplanting fetal human thymus, liver tissue and CD34+ cells. Before allo skin transplantation in humanized NOD/SCID mouse, the ILT3high DCs had been injected. After the skin transplantation from the 5th day, the survival time and morphological changes of the trasplanted grafts were observed. On the 7th day, the rejection degrees of skin grafts observed with HE staining were classified. In vivo, the change of T cell-subsets in peripheral blood was detected by flow cytometry, and ELISA was used to determine the dynamic changes of serum cytokines IL-2 and IL-10 of the recipients after transplantation. Results: After reconstruction of human immune systerm in NOD/SCID mouse, human CD4+ and CD8+ T cells were detected in peripheral blood, and the level increased until 16w˜20w. Allogeneic skin grafts could survive only 9-14d, because of rejectation. In the skin transplantation model, the ILT3high DCs group could better suppress rejction and prolong allogeneic skin graft survival time, reduce graft pathological damage. 7 days after skin transplantation, one-way MLR was used to detect donors and recipients in each group and found that the reactivity of the re-stimulation of ILT3high DCs group was significantly lower than that in other groups (P < 0.05). In vivo, ILT3high DCs could inhibit the secretion of IL-2, and promoted the the secretion of IL-10. And the Tregs level of ILT3high DCs group was significantly higher (p< 0.05vs control group) in peripheral blood, which was consistent with the results of quantitative analysis of Foxp3 mRNA with RT-PCR. Conclusions: This Atifical ILT3high DCs could significantly inhibited the lymphocyte proliferation, activation, and lymphocyte reactivity of the recipient in vivo, and significantly prolong the survival time of skin graft, and reduce the pathological of rejectional damage.

Sodium tanshinone IIA sulfonate prolongs the survival of skin allografts by inhibiting inflammatory cell infiltration and T cell proliferation

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Immunosuppressive effects of ginsenoside-Rd on skin allograft rejection in rats.

Control of allograft rejection in mice by applying a novel neuropeptide, cortistatin

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

Tanshinol Suppresses Cardiac Allograft Rejection in a Murine Model.

The synergistic effects of C. Sinensis with CsA in preventing allograft rejection.

Anti-CCL25 Antibody Prolongs Skin Allograft Survival by Blocking CCR9 Expression and Impairing Splenic T-Cell Function

Effects of the Alkaloid Sinomenine on Expression of TGF-β1 in Rat Renal Allografts

RORγt inverse agonist TF-S14 inhibits Th17 cytokines and prolongs skin allograft survival in sensitized mice

Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft.

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

Cytotoxic T Lymphocyte-associated Protein 4 Acts on Local Draining Lymph Nodes in the Allogeneic Abdominal Skin Flap of a Rat Model to Extend Its Survival

STABLE EXPRESSION OF INTERLEUKIN-10 SUPPRESSES THE DEVELOPMENT OF CHRONIC ALLOGRAFT REJECTION IN RATS:

Ursolic acid promotes robust tolerance to cardiac allografts in mice.

Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a Mitochondria-mediated metabolic disorder

Effect of Sodium Thiosulfate Pre-Treatment on Renal Ischemia-Reperfusion Injury in Kidney Transplantation

Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival

The role of codonopsis saponin in renal transplant immune rejection

Prolonged Survival of Skin Graft by Dendritic Cells Derived Donor-Specific Ilt3 Lentivirus-Transduced Human Cd34(+) Cells in Hu-Nod/Scid Mice